AA
ACOR

ALPS Advisors’s Acorda Therapeutics ACOR Stock Holding History

ALPS Advisors’s Portfolio ACOR Stock Details ACOR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-799
Closed -$275K – 868
2019
Q3 		$275K Sell
799
-41
-5% -$22.3K ﹤0.01% 817
2019
Q2 		$773K Sell
840
-119
-12% -$146K 0.01% 391
2019
Q1 		$1.53M Buy
959
+43
+5% +$77.5K 0.01% 257
2018
Q4 		$1.71M Buy
916
+216
+31% +$470K 0.01% 234
2018
Q3 		$1.65M Buy
700
+131
+23% +$406K 0.01% 275
2018
Q2 		$1.96M Buy
569
+44
+8% +$135K 0.01% 230
2018
Q1 		$1.49M Buy
525
+93
+22% +$278K 0.01% 243
2017
Q4 		$1.11M Buy
432
+49
+13% +$139K 0.01% 243
2017
Q3 		$1.09M Buy
383
+32
+9% +$84.3K 0.01% 235
2017
Q2 		$830K Buy
351
+18
+5% +$35.7K 0.01% 257
2017
Q1 		$838K Sell
333
-36
-10% -$104K 0.01% 233
2016
Q4 		$833K Sell
369
-121
-25% -$288K 0.01% 231
2016
Q3 		$1.23M Sell
490
-49
-9% -$146K 0.01% 212
2016
Q2 		$1.65M Buy
539
+110
+26% +$358K 0.01% 184
2016
Q1 		$1.36M Sell
429
-45
-9% -$187K 0.01% 171
2015
Q4 		$2.43M Sell
474
-85
-15% -$371K 0.02% 162
2015
Q3 		$17.8K Buy
559
+205
+58% +$795K 0.02% 178
2015
Q2 		$1.42M Buy
354
+178
+101% +$688K 0.01% 188
2015
Q1 		$702K Buy
+176
New +$806K 0.01% 202

Other funds holding ACOR

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

ALPS Advisors's ACOR Position: Q4 2019 in Review

ALPS Advisors sold out of Acorda Therapeutics (ACOR) in Q4 2019, closing a stake of 799 shares — an estimated $275K sold.

ALPS Advisors first reported a position in ACOR in Q1 2015 and held it in 19 quarters. The position peaked at $2.43M in Q4 2015. 121 funds tracked by Wall St. Rank hold ACOR as of Q4 2019.

  • ALPS Advisors reported no remaining Acorda Therapeutics position as of Q4 2019 after selling out during the quarter.
  • ALPS Advisors sold 799 Acorda Therapeutics shares in Q4 2019, an estimated $275K.
  • ALPS Advisors first reported a position in Acorda Therapeutics in Q1 2015 and held it in 19 quarters.
  • ALPS Advisors's Acorda Therapeutics position peaked at $2.43M in Q4 2015.
  • 121 funds tracked by Wall St. Rank held Acorda Therapeutics as of Q4 2019.

Based on ALPS Advisors's 13F filing for Q4 2019, filed 7 Feb 2020.